-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOCRYST PHARMACEUTICALS, INC. : RBC CUTS TO SECTOR PERFORM FROM OUTPERFORM; CUTS TARGET PRICE TO $11 FROM $13

Reuters·09/10/2026 09:34:07

Please log in to view news